University of Pennsylvania
Sean Hennessy is Professor of Epidemiology, Director of the Center for Real-World Effectiveness and Safety of Therapeutics, and Director of the Division of Epidemiology at the University of Pennsylvania Perelman School of Medicine. He uses healthcare data to generate real world evidence about the health effects of prescription drugs, with a particular focus in the health effects of potential drug-drug interactions in older adults. He also evaluated an early approach to using insurance data to improve prescribing, finding it ineffective despite its federal mandate. This finding contributed to the omission of drug utilization review programs from Medicare Part D. He co-developed the instrumented difference-in-differences research design for study of the effects of exposures with strong time trends. He was also the senior author of a citizen petition to the US FDA that led to re-labeling of metformin, the best-proven oral drug for diabetes, to permit its use in persons with mild to moderate renal insufficiency. Dr. Hennessy has served on ASCPT's Board of Directors, and is a past president of the International Society for Pharmacoepidemiology and an elected member of the National Academy of Medicine.
Disclosure information not submitted.
Wednesday, March 27, 2024
3:00 PM – 4:45 PM MDT